T1	Participants 83 140	MRI-defined locally advanced T3 resectable rectal cancer:
T2	Participants 542 588	MRI-defined locally advanced T3 resectable RC.
T3	Participants 898 967	Forty-six patients were randomized in arm A and 45 patients in arm B.
